{"id":"https://openalex.org/W7214925633","doi":"https://doi.org/10.3389/fimmu.2026.1964087","title":"Anti-interferon-\u03b3 autoantibodies: immunopathogenesis, diagnostic innovation, and emerging therapeutic strategies in an adult-onset immunodeficiency","display_name":"Anti-interferon-\u03b3 autoantibodies: immunopathogenesis, diagnostic innovation, and emerging therapeutic strategies in an adult-onset immunodeficiency","publication_year":2026,"publication_date":"2026-09-30","ids":{"openalex":"https://openalex.org/W7214925633","doi":"https://doi.org/10.3389/fimmu.2026.1964087","pmid":"https://pubmed.ncbi.nlm.nih.gov/42876531","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13661404"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1964087","doi":"https://doi.org/10.3389/fimmu.2026.1964087","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1964087","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1964087/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1964087/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153672813","display_name":"Chin-Shiang Tsai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]},{"id":"https://openalex.org/I91807558","display_name":"National Cheng Kung University","ror":"https://ror.org/01b8kcc49","country_code":"TW","type":"education","lineage":["https://openalex.org/I91807558"]}],"countries":["TW","US"],"is_corresponding":false,"raw_author_name":"Chin-Shiang Tsai","raw_affiliation_strings":["Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University","Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University","institution_ids":["https://openalex.org/I4210158999","https://openalex.org/I91807558"]},{"raw_affiliation_string":"Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153625973","display_name":"Aristine Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16733864","display_name":"National Taiwan University","ror":"https://ror.org/05bqach95","country_code":"TW","type":"education","lineage":["https://openalex.org/I16733864"]},{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Aristine Cheng","raw_affiliation_strings":["Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine","institution_ids":["https://openalex.org/I16733864","https://openalex.org/I4210131804"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102808539","display_name":"Farha Naz","orcid":"https://orcid.org/0000-0003-1458-488X","observed_orcids":["https://orcid.org/0000-0003-1458-488X"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Farha Naz","raw_affiliation_strings":["Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine","institution_ids":["https://openalex.org/I51556381"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5102808539"],"corresponding_institution_ids":["https://openalex.org/I51556381"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.44127738,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1964087","last_page":"1964087"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adult-onset-immunodeficiency","display_name":"adult-onset immunodeficiency","score":0.8619999885559082},{"id":"https://openalex.org/keywords/anti-interferon-gamma-autoantibodies","display_name":"anti-interferon-gamma autoantibodies","score":0.9750000238418579},{"id":"https://openalex.org/keywords/acquired-immunodeficiency","display_name":"acquired immunodeficiency","score":0.843999981880188},{"id":"https://openalex.org/keywords/nontuberculous-mycobacteria","display_name":"nontuberculous mycobacteria","score":0.9039999842643738},{"id":"https://openalex.org/keywords/intracellular-pathogens","display_name":"intracellular pathogens","score":0.5920000076293945},{"id":"https://openalex.org/keywords/immunopathogenesis","display_name":"immunopathogenesis","score":0.8209999799728394},{"id":"https://openalex.org/keywords/hla-susceptibility","display_name":"HLA susceptibility","score":0.7770000100135803},{"id":"https://openalex.org/keywords/molecular-mimicry","display_name":"molecular mimicry","score":0.8629999756813049},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9959999918937683},{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/azathioprine","display_name":"azathioprine","score":0.9240000247955322},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.8080000281333923},{"id":"https://openalex.org/keywords/autoantibody-titers","display_name":"autoantibody titers","score":0.6899999976158142},{"id":"https://openalex.org/keywords/east-and-southeast-asia","display_name":"East and Southeast Asia","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.722000002861023},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6966000199317932},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6299999952316284},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.5716000199317932},{"id":"https://openalex.org/C2777607303","wikidata":"https://www.wikidata.org/wiki/Q641307","display_name":"Immunodeficiency","level":3,"score":0.4521999955177307},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.44929999113082886},{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.44850000739097595},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4262000024318695},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.41449999809265137},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.37299999594688416},{"id":"https://openalex.org/C2779605438","wikidata":"https://www.wikidata.org/wiki/Q2697833","display_name":"Abatacept","level":4,"score":0.32679998874664307},{"id":"https://openalex.org/C519536355","wikidata":"https://www.wikidata.org/wiki/Q21021151","display_name":"Repurposing","level":2,"score":0.3118000030517578},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3068999946117401},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.30169999599456787},{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.28519999980926514},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.27970001101493835},{"id":"https://openalex.org/C82157600","wikidata":"https://www.wikidata.org/wiki/Q2671652","display_name":"Diagnostic test","level":2,"score":0.27619999647140503},{"id":"https://openalex.org/C2780644213","wikidata":"https://www.wikidata.org/wiki/Q704930","display_name":"Progressive multifocal leukoencephalopathy","level":3,"score":0.2648000121116638},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.2556000053882599}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001323","descriptor_name":"Autoantibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1964087","doi":"https://doi.org/10.3389/fimmu.2026.1964087","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1964087","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1964087/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13661404","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13661404/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13661404/pdf/fimmu-17-1964087.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42876531","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42876531","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:9f5e6786139048569c5e301e607f5071","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/9f5e6786139048569c5e301e607f5071","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1964087","doi":"https://doi.org/10.3389/fimmu.2026.1964087","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1964087","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1964087/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324663","display_name":"National Cheng Kung University","ror":"https://ror.org/01b8kcc49"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214925633.pdf","grobid_xml":"https://content.openalex.org/works/W7214925633.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W354123566","https://openalex.org/W2036292718","https://openalex.org/W2047392472","https://openalex.org/W2109401131","https://openalex.org/W2113560700","https://openalex.org/W2126605488","https://openalex.org/W2136745465","https://openalex.org/W2163694362","https://openalex.org/W2164138943","https://openalex.org/W2515952005","https://openalex.org/W2579739608","https://openalex.org/W2606794813","https://openalex.org/W2726907951","https://openalex.org/W2729234711","https://openalex.org/W2743880178","https://openalex.org/W2791604625","https://openalex.org/W2795707233","https://openalex.org/W2907734881","https://openalex.org/W2941279955","https://openalex.org/W2963917496","https://openalex.org/W2969224962","https://openalex.org/W2971897192","https://openalex.org/W3003805759","https://openalex.org/W3005664566","https://openalex.org/W3025126813","https://openalex.org/W3037971555","https://openalex.org/W3044418753","https://openalex.org/W3046983918","https://openalex.org/W3083433212","https://openalex.org/W3170470841","https://openalex.org/W3175255495","https://openalex.org/W3197388139","https://openalex.org/W4211004034","https://openalex.org/W4308101846","https://openalex.org/W4311829267","https://openalex.org/W4311848823","https://openalex.org/W4323971811","https://openalex.org/W4327568817","https://openalex.org/W4386863728","https://openalex.org/W4388556774","https://openalex.org/W4392883110","https://openalex.org/W4405396772","https://openalex.org/W4410227361","https://openalex.org/W7124472549","https://openalex.org/W7138840027"],"related_works":["https://openalex.org/W7163169891","https://openalex.org/W4410336967","https://openalex.org/W2615971495","https://openalex.org/W4311848823","https://openalex.org/W4319294269","https://openalex.org/W7161024525","https://openalex.org/W3175255495","https://openalex.org/W7136853678","https://openalex.org/W7168376678","https://openalex.org/W4414008982"],"abstract_inverted_index":{"Adult-onset":[0],"immunodeficiency":[1,10],"with":[2,22,125,167],"anti\u2013interferon-\u03b3":[3],"autoantibodies":[4],"(AIGA)":[5],"is":[6],"a":[7,62,107,119,160,192],"rare":[8],"acquired":[9],"increasingly":[11],"recognized":[12],"in":[13,52,111],"East":[14],"and":[15,25,45,54,69,88,91,102,127,139,153,170,205],"Southeast":[16],"Asia,":[17],"characterized":[18],"by":[19],"disseminated":[20],"infections":[21],"nontuberculous":[23],"mycobacteria":[24],"other":[26],"intracellular":[27],"pathogens.":[28],"Recent":[29],"studies":[30],"have":[31],"refined":[32],"our":[33],"understanding":[34],"of":[35,43,76,79,99],"its":[36],"immunopathogenesis,":[37],"including":[38,179],"HLA-linked":[39],"susceptibility,":[40],"epitope-specific":[41],"neutralization":[42],"IFN-\u03b3,":[44],"molecular":[46],"mimicry,":[47],"while":[48],"highlighting":[49],"persistent":[50],"gaps":[51],"diagnosis":[53],"treatment.":[55,172],"This":[56],"Perspective":[57],"synthesizes":[58],"emerging":[59,140,176],"evidence":[60,142],"into":[61],"clinically":[63],"oriented":[64],"framework":[65],"spanning":[66],"diagnosis,":[67],"monitoring,":[68],"immunomodulatory":[70],"therapy.":[71,207],"We":[72,105,173],"discuss":[73],"functional":[74],"confirmation":[75],"AIGA,":[77],"repurposing":[78],"the":[80,130],"QuantiFERON-TB":[81],"platform":[82],"as":[83,96,129,191],"an":[84],"accessible":[85],"screening":[86],"strategy,":[87],"quantitative":[89],"titers":[90],"\u00b9":[92],"8":[93],"F-FDG":[94],"PET":[95],"complementary":[97],"biomarkers":[98],"disease":[100],"activity":[101],"treatment":[103],"response.":[104],"propose":[106,159],"clinical":[108],"decision":[109],"pathway":[110],"which":[112],"refractory":[113,137],"or":[114],"progressive":[115],"infection,":[116],"rather":[117],"than":[118],"fixed":[120],"titer":[121],"threshold,":[122],"triggers":[123],"immunomodulation,":[124],"rituximab":[126],"cyclophosphamide":[128],"best-supported":[131],"induction":[132],"strategies,":[133,178],"daratumumab":[134],"reserved":[135],"for":[136,145,202],"cases,":[138],"AIGA-specific":[141],"supporting":[143],"azathioprine":[144],"maintenance.":[146],"Recognizing":[147],"heterogeneous":[148],"access":[149],"to":[150,186],"specialized":[151],"testing":[152,169],"biologics":[154],"across":[155],"AIGA-endemic":[156],"regions,":[157],"we":[158,199],"resource-stratified":[161],"approach":[162],"integrating":[163],"widely":[164],"available":[165],"markers":[166],"referral-based":[168],"resource-adapted":[171],"also":[174],"highlight":[175],"antigen-specific":[177],"chimeric":[180],"autoantibody":[181],"receptor":[182],"T":[183],"cells":[184],"engineered":[185],"eliminate":[187],"autoantibody-producing":[188],"B":[189],"cells,":[190],"future":[193],"direction":[194],"toward":[195],"durable":[196],"remission.":[197],"Finally,":[198],"outline":[200],"priorities":[201],"prospective":[203],"validation":[204],"biomarker-guided":[206]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-10-01T00:00:00"}